EcoR1 Capital LLC 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 6:13 pm Purchase |
2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 5,617,719 9.990% |
1,766,212 (+45.86%) |
Filing |
| 2023-01-13 4:33 pm Sale |
2023-01-11 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 3,851,507 9.980% |
-425,000 (-9.94%) |
Filing |
| 2022-04-26 12:58 pm Purchase |
2022-04-21 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 4,276,507 11.100% |
719,000 (+20.21%) |
Filing |
| 2022-02-14 4:01 pm Unchanged |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 3,557,507 9.400% |
0 (Unchanged) |
Filing |
| 2021-10-22 4:46 pm Purchase |
2021-10-12 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 3,557,507 9.400% |
3,557,507 (New Position) |
Filing |